Jeremy Grushcow

CEO and Co-Founder at Juniper Genomics

Founder

Sequence Bio· Summer 2019 🇨🇦 Toronto, Ontario, Canada

in LinkedIn 𝕏 @crossborderbio

2020Founder· Juniper Genomics

Founder · since 2020

Company

Juniper Genomics

Role

Founder and CEO

current

Stage

—

no public source

Raised

—

no public source

Based

Toronto, Ontario, Canada

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

Summer 2019

Experience

Career

Juniper Genomics
Founder
Founder and CEO · Toronto, Ontario, Canada · 2020 – Present
2020
Cyclica
Operating Partner · Toronto, Ontario, Canada · 2020 – 2021
2020
Sequence Bio
Chief Business Officer · 2015 – 2019
2015
Bloom Burton & Co.
Consultant · 2015 – 2016
2015
Antibe Therapeutics Inc
Executive Vice President, Strategic Development · Greater Toronto Area, Canada · 2013 – 2015
2013
Oncolytics Biotech Inc.
General Counsel · 2013
2013
Norton Rose
Partner · 2011 – 2013
2011
Ogilvy Renault
Attorney and Foreign Legal Consultant · 2008 – 2011
2008
Shearman and Sterling
Associate · 2005 – 2008
2005
Kirkland & Ellis LLP
Associate · 2003 – 2005
2003

Bio

Ph.D. in Molecular Genetics and Cell Biology (University of Chicago, 2000); J.D. with Honors (University of Chicago Law School, 2003). Previously: CBO, Sequence Bio S19 (Raised >$10m; LOIs signed with Sema4, Helix and Biogen); EVP, Strategic Development, Antibe Therapeutics (International partnerships, public company financings and disclosures; preclinical through Phase 1 for a novel pain therapeutic) Best dog dad ever; 7 out of 10 human dad.